1.54
-0.24 (-13.48%)
-0.24 (-13.48%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
Big Cap Pro
Monthly Subscription
for only
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
Level 1 Starter
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Celsion Corp | CLSN | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
-0.24 | -13.48% | 1.54 | 09:23:53 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.78 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
1.54 | 1.55 | 0.01 | - | - |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
3,666 | 1,565,017 | 12,545,259 | 0.4305 - 6.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:23:53 | formt | 500 | $ 1.54 | USD |
Celsion Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 57.62M | 37.42M | 33.80M | $ 500.00k | $ - | -0.76 | -1.90 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
Celsion News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.9121 | 2.80 | 0.9121 | 1.62 | 61,029,751 | 0.6279 | 68.84% |
1 Month | 0.68 | 2.80 | 0.68 | 1.50 | 19,993,338 | 0.86 | 126.47% |
3 Months | 0.4784 | 2.80 | 0.465 | 1.38 | 7,679,075 | 1.06 | 221.91% |
6 Months | 1.24 | 2.80 | 0.4305 | 1.31 | 3,894,563 | 0.30 | 24.19% |
1 Year | 1.52 | 6.50 | 0.4305 | 1.73 | 2,927,081 | 0.02 | 1.32% |
3 Years | 2.62 | 6.50 | 0.4305 | 1.78 | 1,106,350 | -1.08 | -41.22% |
5 Years | 18.90 | 24.92 | 0.4305 | 2.85 | 1,158,618 | -17.36 | -91.85% |
Celsion Description
Celsion Corp is active in the biotechnology market. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in Phase III clinical trial for the treatment of primary liver cancer and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. |